Intellia Therapeutics, Inc. (NTLA)
12.72
-0.35
(-2.68%)
USD |
NASDAQ |
Oct 12, 14:58
Intellia Therapeutics Net Income (TTM) : -399.98M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -399.98M |
| March 31, 2026 | -394.60M |
| December 31, 2025 | -412.69M |
| September 30, 2025 | -445.81M |
| June 30, 2025 | -480.19M |
| March 31, 2025 | -525.91M |
| December 31, 2024 | -519.02M |
| September 30, 2024 | -522.28M |
| June 30, 2024 | -508.80M |
| March 31, 2024 | -485.50M |
| December 31, 2023 | -481.19M |
| September 30, 2023 | -462.44M |
| June 30, 2023 | -453.44M |
| March 31, 2023 | -430.44M |
| December 31, 2022 | -474.19M |
| September 30, 2022 | -442.02M |
| June 30, 2022 | -400.43M |
| March 31, 2022 | -368.56M |
| December 31, 2021 | -267.89M |
| September 30, 2021 | -228.85M |
| Date | Value |
|---|---|
| June 30, 2021 | -185.04M |
| March 31, 2021 | -148.63M |
| December 31, 2020 | -134.23M |
| September 30, 2020 | -120.32M |
| June 30, 2020 | -116.11M |
| March 31, 2020 | -109.40M |
| December 31, 2019 | -99.53M |
| September 30, 2019 | -90.32M |
| June 30, 2019 | -89.39M |
| March 31, 2019 | -85.93M |
| December 31, 2018 | -85.34M |
| September 30, 2018 | -90.24M |
| June 30, 2018 | -82.89M |
| March 31, 2018 | -76.27M |
| December 31, 2017 | -67.54M |
| September 30, 2017 | -54.14M |
| June 30, 2017 | -46.27M |
| March 31, 2017 | -37.58M |
| December 31, 2016 | -31.63M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Twist Bioscience Corp. | -136.72M |
| Beam Therapeutics, Inc. | -85.43M |
| Prime Medicine, Inc. | -187.89M |
| Moderna, Inc. | -3.151B |
| Q32 Bio, Inc. | 33.79M |